Results 91 to 100 of about 8,815 (184)

Bench Testing Analysis of Perforation Management in the Setting of Bifurcation Coronary Intervention

Catheterization and Cardiovascular Interventions, Volume 107, Issue 4, Page 888-897, March 1, 2026.
ABSTRACT Background Management of coronary perforation in bifurcation lesions with covered stents remains challenging. Aims We aimed to describe a proper practice and toolbox for “jailed‐branch” management after covered stent deployment. Methods Using a bench model, we tested various wires with a 120° angulated microcatheter for their ability to ...
Rayyan Hemetsberger, Anass Maaroufi, Kevin Hamzaraj, Judit Andreka, Mohammad Abdelghani, Serdar Farhan, Daniel Lootz, Johannes Gollmer, Nader Mankerious, Christian Hengstenberg, Tom W. Johnson, Gabor G. Toth   +11 more
wiley   +1 more source

Indobufen Dual Antiplatelet Therapy (DAPT) Versus Aspirin Dual Antiplatelet Therapy (DAPT) After Percutaneous Coronary Intervention (PCI): A Systematic Review and Meta‐Analysis

Catheterization and Cardiovascular Interventions, Volume 107, Issue 4, Page 1225-1236, March 1, 2026.
ABSTRACT Background Dual antiplatelet therapy (DAPT), which combines aspirin with a P2Y12 receptor inhibitor, is considered the standard of care for patients who have had percutaneous coronary intervention (PCI). This study aimed to compare indobufen‐based (DAPT) to aspirin‐based (DAPT) after PCI.
Omar Saeed, Abdelrahman Saeed, Osama Barakat, Abdulaziz Bawjeh, Tuğba Saka, Tasneem Mustafa Yousif, Aeshah Mohammed Adim, Muhammed Elhadi, Mamas A. Mamas   +8 more
wiley   +1 more source

Paclitaxel- or sirolimus-coated balloons used for ArterioVEnous fistulas-2 (PAVE-2): study protocol for a randomised controlled trial to determine the efficacy of paclitaxel- or sirolimus-coated balloons in arteriovenous fistulas used for haemodialysis

Trials
Background In view of the conflicting results from previous studies, the benefit of paclitaxel-coated balloons for arteriovenous fistulas is uncertain and equipoise remains. Although an industry-led trial testing the efficacy of sirolimus-coated balloons
Narayan Karunanithy, Sam Norton, Francis Calder, Neelanjan Das, Niamh Dooley, Lusine Hakobyan, Robert Jones, Soundrie Padayache, Chloe Spriggs, Kate Steiner, Rebecca Suckling, Michael G. Robson   +11 more
doaj   +1 more source

Cephalalgia—A “Tricky” Symptom for the Cardiologist: Acute Coronary Syndrome Presenting as Headache

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Rarely, headache may be the primary or sole symptom of acute myocardial ischemia; clinicians should recognize such atypical presentations and obtain an electrocardiogram and cardiac biomarkers to establish the diagnosis and guide urgent treatment.
Alexandros Vassiliades, Varnavas Dimitriades, Vasiliki Vanesa Stylianou, Marios Pavlou, Panagiota Georgiou, Lorentzos Kapetis, Dimitrios Patestos, Michalis Tsielepis, George Bazoukis   +8 more
wiley   +1 more source

Coronary Angioplasty with Drug-Coated Balloons: Pharmacological Foundations, Clinical Efficacy, and Future Directions

Medicina
Drug-coated balloons (DCBs) have transformed percutaneous coronary intervention (PCI) by delivering antiproliferative drugs directly to the arterial wall, offering a stent-less approach that mitigates the risks associated with permanent metallic implants.
Valentin Chioncel, Flavius Gherasie, Alexandru Iancu, Anamaria-Georgiana Avram   +3 more
doaj   +1 more source

Ninjurin1 in cardiovascular and vascular biology: From molecular mechanisms to therapeutic opportunities

Clinical and Translational Medicine, Volume 16, Issue 3, March 2026.
NINJ1 mediates PMR in cardiovascular cell death, releasing DAMPs that amplify vascular inflammation. Dual NINJ1 paradox: membrane‐bound form drives endothelial NF‐κB/CXCL‐8 inflammation while soluble form provides atheroprotection. Pericyte NINJ1 regulates the critical balance between angiogenic sprouting and vessel maturation in ischaemic tissues ...
Muhammad Mamunur Rashid Mahib
wiley   +1 more source

An Exploratory Study on the Pathogenic Role of Faecal Extracellular Vesicles in Metabolic Dysfunction‐Associated Steatotic Liver Disease Progression and in Drug‐Induced Liver Injury

Journal of Extracellular Vesicles, Volume 15, Issue 3, March 2026.
Fecal extracellular vesicles (fEVs) from DILI patients have a distinct bacterial profile. This study provides evidence that bacterial EVs enter the bloodstream. DILI and MASLD F≥3 fEVs increase the pro‐inflammatory response and hepatocyte steatosis. FEVs from DILI patients enhance the hepatotoxic potential of diclofenac.
Antonio J. Ruiz‐Malagón, Marina Herraiz‐Vilela, Jose Pinazo‐Bandera, Juan Pedro Toro‐Ortiz, Carlos López‐Gómez, Ailec Ho‐Plagaro, Lourdes Garrido‐Sánchez, Mercedes Robles‐Díaz, Bernard Taminiau, Georges Daube, Judith Sanabria‐Cabrera, Gonzalo Matilla‐Cabello, Maria Isabel Lucena, Raúl J. Andrade, Eduardo García‐Fuentes, Miren García‐Cortes, Cristina Rodriguez‐Diaz   +16 more
wiley   +1 more source

Paclitaxel Drug-Coated Balloons

JACC: Cardiovascular Interventions, 2012
Loh, Joshua P., Waksman, Ron
openaire   +1 more source

Novel PMVs/ZIP4/Zinc/Prelamin A Axis Promotes Nuclear Dysmorphism and Vascular Aging in Humans and Rodents Post‐Injury: Effective Treatment With Platelet Membrane‐Coated ZIF‐8 Nanoparticles

Aging Cell, Volume 25, Issue 3, March 2026.
Interventional therapy and surgical injury induce nuclear dysmorphism and vascular aging. Nuclear dysmorphism is positively associated with vascular aging. Novel PMVs/ZIP4/Zinc/preLamin A axis plays a key role in injury‐induced nuclear dysmorphism and vascular aging.
Tengzhi Ma, Han Bao, Zhijue Xu, He Ren, Wenhao Tian, Jiahe Chen, Zhongqian Liu, Xinwu Lu, Fan Lv, Qingping Yao, Yingxin Qi, Kai Huang   +11 more
wiley   +1 more source

Acotec Drug-Coated Balloon Catheter

JACC: Cardiovascular Interventions, 2016
Xin Jia, Jiwei Zhang, Baixi Zhuang, Weiguo Fu, Danming Wu, Feng Wang, Yu Zhao, Pingfan Guo, Wei Bi, Shenming Wang, Wei Guo   +10 more
openaire   +1 more source